The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2017
Filed:
Aug. 02, 2012
Applicants:
Aiping Cheng, Huddinge, SE;
Neeraj Garg, Huddinge, SE;
Lars Krüger, Huddinge, SE;
Joakim Löfstedt, Huddinge, SE;
Eva Koch, Huddinge, SE;
Konrad Koehler, Huddinge, SE;
Lars Hagberg, Huddinge, SE;
Daniel Nöteberg, Huddinge, SE;
Inventors:
Aiping Cheng, Huddinge, SE;
Neeraj Garg, Huddinge, SE;
Lars Krüger, Huddinge, SE;
Joakim Löfstedt, Huddinge, SE;
Eva Koch, Huddinge, SE;
Konrad Koehler, Huddinge, SE;
Lars Hagberg, Huddinge, SE;
Daniel Nöteberg, Huddinge, SE;
Assignee:
Karo Pharma AB, Stockholm, SE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 251/48 (2006.01); A61K 31/381 (2006.01); C07D 261/08 (2006.01); C07D 207/327 (2006.01); C07D 213/58 (2006.01); C07D 215/12 (2006.01); C07D 217/14 (2006.01); C07D 231/12 (2006.01); C07D 233/64 (2006.01); C07D 235/16 (2006.01); C07D 277/30 (2006.01); C07D 277/34 (2006.01); C07D 295/155 (2006.01); C07D 307/54 (2006.01); C07D 307/68 (2006.01); C07D 307/87 (2006.01); C07D 317/60 (2006.01); C07D 333/20 (2006.01); C07D 409/10 (2006.01); C07D 413/10 (2006.01); C07C 209/68 (2006.01); A61K 31/155 (2006.01); A61K 31/341 (2006.01); A61K 31/416 (2006.01); A61K 31/42 (2006.01); A61K 31/4418 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); C07D 215/14 (2006.01); C07D 217/16 (2006.01); C07D 333/24 (2006.01);
U.S. Cl.
CPC ...
C07C 251/48 (2013.01); A61K 31/155 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/416 (2013.01); A61K 31/42 (2013.01); A61K 31/4418 (2013.01); A61K 31/47 (2013.01); A61K 31/472 (2013.01); C07C 209/68 (2013.01); C07D 207/327 (2013.01); C07D 213/58 (2013.01); C07D 215/12 (2013.01); C07D 215/14 (2013.01); C07D 217/14 (2013.01); C07D 217/16 (2013.01); C07D 231/12 (2013.01); C07D 233/64 (2013.01); C07D 235/16 (2013.01); C07D 261/08 (2013.01); C07D 277/30 (2013.01); C07D 277/34 (2013.01); C07D 295/155 (2013.01); C07D 307/54 (2013.01); C07D 307/68 (2013.01); C07D 307/87 (2013.01); C07D 317/60 (2013.01); C07D 333/20 (2013.01); C07D 333/24 (2013.01); C07D 409/10 (2013.01); C07D 413/10 (2013.01);
Abstract
Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which Rto Rhave meanings as defined in the Specification, are useful as estrogen receptor ligands.